Page last updated: 2024-08-23

daunorubicin and Infection, Toxoplasma gondii

daunorubicin has been researched along with Infection, Toxoplasma gondii in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barkhan, P; Black, PJ; Rose, MS1

Other Studies

2 other study(ies) available for daunorubicin and Infection, Toxoplasma gondii

ArticleYear
Fatal outcome after combined therapy for myeloblastic leukaemia and toxoplasmosis.
    Lancet (London, England), 1973, Mar-31, Volume: 1, Issue:7805

    Topics: Autopsy; Bone Marrow; Bone Marrow Cells; Cytarabine; Daunorubicin; Humans; Leucovorin; Leukemia, Myeloid, Acute; Pyrimethamine; Toxoplasmosis

1973
Fatal outcome after combined therapy for myeloblastic leukaemia and toxoplasmosis.
    Lancet (London, England), 1973, Mar-17, Volume: 1, Issue:7803

    Topics: Aged; Antineoplastic Agents; Bone Marrow Diseases; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Male; Pyrimethamine; Sulfamethazine; Toxoplasmosis

1973